Therapeutic and diagnostic methods using soluble t cell surface molecules

Abstract From the Canadian patent

The present invention is directed to the measurement of soluble T cell growth factor receptors soluble T cell, differentiation antigens or related soluble molecules or, fragments thereof and the use of such measurements in the diagnosis and therapy of diseases and disorders. The measurement of such molecules can be valuable in monitoring the effect of a therapeutic treatment on a subject detecting and/or staging a disease in a subject and in, differential diagnosis of a physiological condition in a subject. These measurements can also aid in predicting therapeutic outcome and in evaluating and monitoring the immune status of patients. In specific embodiments measurements of serum or, plasma …